Novartis, which bought the biotech firm in 2018, announced that the company’s top scientists have left, and news reports say it’s because they were involved in using manipulated data to get the gene therapy Zolgensma approved.

The same Winnipeg lab that sent Ebola and Henipah viruses to Beijing recently removed a number of researchers for an “administrative issue.”

The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.

Despite growing support, respondents still have concerns when it comes to scientific transparency and integrity.

A study estimates that 0.15 percent of genetics articles are retracted, most commonly for duplication and plagiarism.

An external consultant will review the work environment of the institution’s Australian Centre for Ancient DNA, led by evolutionary molecular biologist Alan Cooper.

For years, a committee at CNRS has bucked the recommendations of its researchers to hire two social scientists, and colleagues conclude that prejudice is at play.

Five independent groups got different results in a drug-response experiment, despite sharing protocols, reagents, and cell lines. The researchers identify technical variables that could be to blame.

Her departure follows her denial of tenure.